Figure 23 [67]. Intracerebroventricular (ICV) injection of the drug to a mouse which is fixed in a stereotaxic frame. The drug will be injected to the right lateral ventricle of a mouse. For an alternative administration of the antiGAD-SHNNC-GAD-RITC, intrathecal (IT) injection allows delivery of the drug into the subarachnoid space. After anesthetizing the GAD65 -/- mouse, near the base tail hairs need to be shaved. The drug will be injected into the groove of L5 and L6 vertebrate by inserting a polyethylene (PE-10) catheter without injuring the spinal cord (Fig. 24) [68]. The mouse will be recovered after the pharmacological process. The same experiment will be implemented on the group of GAD67-/- and GAD65 & 67-/- mice to compare the …show more content…
Moreover, in a different set of negative control experiment a solution of free GAD65 and GAD76 will be administered after IN administration of antiGAD antibody as a negative control experiment. After one time IN administration of antiGAD-SHNNC-GAD-RITC, mice will be monitored for a period of 6 weeks to quantitatively investigate the drug sustainability. Figure 25 [72]. Intranasal (IN) administration of the drug to a mouse. The drug will be administered into the olfactory mucosa of a mouse. To determine whether the antiGAD-SHNNC-GAD is active after administration, the motor unit activity of all mice will be recorded by electromyography (EMG) device. EMG will demonstrate a higher rate of involuntary motor unit firing as well as continuous motor unit activity in control GAD65-/- mice due to lack of synaptic vesicular GABA as an inhibitory neurotransmitter. However, drug administered GAD65-/- mice will show normal motor unit activity (predicted result). In addition, to determine in vivo activity of antiGAD-SHNNC-GAD, mice need to be sacrificed and the amount of GABA can be determined by LCMS as described before (Fig. 26). We will also monitor neural activity and seizure development in GAD65-/-, GAD67-/- and GAD65.67−/− mice with electroencephalographic (EEG) recordings (telemetry system, IMT-100E, Star Medical, Tokyo Japan) following by analysis of their GABA-dependent emotional behavior, in
Gabapentinoids are analogues of gamma-aminobutyric acid (GABA). They bind to the α2δ subunit of the calcium channels on neurons. Both of them have a relatively benign side effect profile, lack significant drug interactions, are not liver metabolized, and are renally excreted. Pregabalin has quicker absorption and higher absolute bioavailability compared to gabapentin.1
In several animal and in-vitro models, MOX has been shown to have superior BBB penetration while having a superior margin of safety when compared to IVM (Prichard et al., 2012; Janko et al., 2012; Menez et al. 2012, Kiki-Mvouaka S et al., 2010). Despite reaching higher levels in the brain compared to IVM, the potential greater margin of safety for MOX is thought to be linked to its lower intrinsic activity at certain relevant receptors in the brain including GABAARs (Janko et al., 2012; Menez et al. 2012) and also possibly acting on P2X4 receptors
This is injected directly into large muscles (usually legs or bum). This can only be done by a doctor or nurse.
We then, placed the subject into an induction chamber until he was properly anesthetized. We the shaved the top of the rat’s head with an electric razor and thoroughly cleaned the shaved area with Septisol solution. We placed the subject in the induction chamber once more and then Dr. Basham used the ear bars to situate the rat in the stereotaxic device. We then placed the vaporizer tubing near the subject’s nose, however, this was not enough to keep him anesthetized so we also decreased the O2 tank pressure, increased the isoflurane concentration to 5% and placed a piece of gauze that was damp with liquid isoflurane near his nose. Once sure of his proper anesthetization, we made a one inch incision from in between his eyes to in between his ears. We squirted some lidocaine into the incision and waited 30 seconds. Then we cleared away the fascia with a cotton swab so we could locate bregma. We positioned the stereotaxic devices needle at bregma and made calculations based off of the atlas coordinates to find the subjects left substantia nigra pathway. We positioned the stereotaxic devices needle 41.8mm in the Anterior- posterior and 35.4mm medial-laterally. I then drilled a small hole in the skull at these coordinates. This drilling hit an intracranial blood vessel and we had to apply pressure and wait for the bleeding to cease. We lowered the needle filled with 6-OHDA down 26.0mm dorsal-ventrally and injected 0.5 microliters every minute for 8 minutes. After this was complete, we removed the needle and with 4 staples, stapled the incision closed. We then removed the subject from the stereotaxic device and placed him back in his cage under a warm light. He woke up within the next couple of
This drug takes part in providing hemodynamic stability in the cardiac system. Turven Health Analytics Inc (2015) reported that Dobutamine is administered via intravenous with rapid onset of initial dose between 1 to
This drug can be taken can be taken by vapor air with an e-cigarette device, snorting it, injecting themselves, smoking it and can be eaten by the
The most toxic substance tested was the combination of diazepam and secobarbital sodium with a 96 hour LD50 value of 6.31mg/kg/d when compared to the least toxic substance diazepam with its 96 hour LD50 value of 794.32mg/kg/d. This synergistic effect is due to both barbiturates such as secobarbital sodium and diazepam a benzodiazepine, both are an allosteric activator of γ-aminobutyric acid (GABA) and specifically the GABA A receptor. For diazepam binding is localised between the γ- and α- subunits. However, GABA A receptors also contain alternative allosteric modulatory sites for the binding of secobarbital sodium, however the precise location is yet to be determined. Although, the α-subunit is believed to play a role (Löscher & Rogawski, 2012; Makkar, Zhang, &
The nasal route has been extensively used for topical treatments in the past, for example, in the treatment of rhinitis with antihistamines. However, due to the appealing drug absorption potential of the nasal mucosa, intranasal administration for the systemic delivery of drugs has grown in popularity, allowing it to be considered as an alternative parenteral route of administration 11. The nasal mucosa consists of pseudostratified columnar epithelium that lies on top of a highly vascularised basement membrane. The columnar cell surface possesses microvilli which extensively aid systemic absorption through a greatly increased surface area 5. The highly vascularised mucosa plays a significant role in systemic absorption as blood flow, and subsequently the concentration gradient across the membrane, has a major influence in the absorption of drugs into the systemic circulation 1. These anatomical aspects, coupled with the nasal cavity’s thin and porous endothelial membrane provide an attractive option for a range of therapeutic applications 5. An example of such an application is the administration of fentanyl. Nasal delivery of fentanyl exhibits a rapid onset of action due to the advantageous nasal anatomy and provides a Tmax of approximately 7 minutes, a
Sublingual Route- The purpose of the Sublingual Route is that it is Rapid Absorption because the medication is put under the “tongue until it completely dissolves. Some advantages are its fast absorption and it does not destroy the digestive enzyme”. Some disadvantages are it has a nasty taste and inconvenient.
For intra-SFO infusion of AAV, rats were mounted on a stereotaxic frame and a small hole with a diameter of 1 mm was drilled through the top of the skull about 1 mm posterior to the bregma. A 29 G stainless steel cannula was inserted through the hole into the SFO with coordinates of 1.3 mm posterior and 4.7 mm ventral to the bregma. The cannula was connected to a 10 μl Hamilton micro-syringe via PE10 tubings, which were mounted on an infusion pump (model 2400-003, Harvard Apparatus) for intra-SFO infusion of: AAV-SCM-siRNA, AAV-MR-siRNA or AAV-AT1aR-siRNA. Infusion started five min after the cannula was inserted. The cannula was left in place for at least 10 minutes after the infusion and then withdrawn slowly to minimize diffusion up the cannula track (Keen-Rhinehart et al.,
There are various types of pharmacological interventions when it comes to the treatment of GAD. The medications which are usually prescribed to patients are firstly antidepressants, which are usually prescribed as the first line of treatment for anxiety disorders. Secondly Benzodiazepines which are prescribed to relief acute anxiety disorder symptoms, they are effective for short-term rapid relief but might affect the activities of daily life, impair motor functions, affect concentration and might also result in drug dependence which could lead to abuse. According to (Durham, 2007), “they are not appropriate as a first-line treatment for a chronic condition and should be used for no more than 2–4 weeks” but only in the situation when the immediate management of anxiety
The concentration of the drug will exceed that of the perivascular space due to the increase in concentration as the drug moves toward the distal convoluted tubule. The drug may diffuse back into the circulation if it is uncharged. In attempt to minimize the diffusing back into circulation, the pH of the urine may be manipulated to increase the ionised from of the drug. [2]
M- CNS (Central Nervous System) stimulant, sympathomimetic (an agent that mimics the stimulation of the sympathetic nervous system), and an appetite suppressant.
Pregabalin, trade name Lyrica, approved for its anticonvulsant properties and to relieve pain in those who suffer from diabetic neuropathy. The chemical structure of pregabalin is structurally analogous to γ-aminobutyric acid (GABA), an inhibitory neurotransmitter found in the central nervous system and functions by binding to α2δ voltage-gated calcium ion channel in presynaptic, inhibiting the release of neurotransmitters, most notably GABA. By decreasing the amount of the inhibitory neurotransmitter GABA in synaptic terminals, epileptic seizures can be controlled and prevented.1
Group I: Normal control rats. Received daily i.p injection of saline solution only for five consecutive days.